Who owns ALLARITY THERAPEUTICS INC?
- Ticker: ALLR
- CUSIP Number: 016744500
Tip: Access positions for across all investors
Analyze quarterly positions in Allarity Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Allarity Therapeutics stock
Who bought or sold ALLARITY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Private Advisor | 279k | $441k | 100% | Sep 2025 |
|
| Vanguard Group | 247k | $390k | 100% | Sep 2025 |
|
| Geode Capital Management | 152k | $240k | 200% | Sep 2025 |
|
| State Street Corporation | 138k | $217k | 100% | Sep 2025 |
|
| Citadel Advisors | 94k | $149k | 100% | Sep 2025 |
|
| Renaissance Technologies | 66k | $105k | 100% | Sep 2025 |
|
| Northern Trust | 44k | $69k | 100% | Sep 2025 |
|
| Two Sigma Investments | 14k | $22k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 7.00 | $10.000200 | 0% | Sep 2025 |
|
| Danske Bank A/s | 1.00 | $2.000000 | 100% | Sep 2025 |
|
Who sold out of Allarity Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 51k | $52k |
| UBS Group | Jun 2025 | 48k | $49k |
| Jane Street | Jun 2025 | 26k | $27k |
| Squarepoint Ops | Jun 2025 | 15k | $15k |
| Tower Research Capital | Jun 2025 | 3.1k | $3.1k |